Zetia

[ezetimibe]

DOSAGE AND ADMINISTRATION

The patient should be placed on a standard cholesterol-lowering diet before receiving ZETIA and should continue on this diet during treatment with ZETIA.

The recommended dose of ZETIA is 10 mg once daily. ZETIA can be administered with or without food. ZETIA may be administered with an HMG-CoA reductase inhibitor for incremental effect. For convenience, the daily dose of ZETIA may be taken at the same time as the HMG-CoA reductase inhibitor, according to the dosing recommendations for the HMG-CoA reductase inhibitor.

Text Continues Below

---

Patients with Hepatic Insufficiency

No dosage adjustment is necessary in patients with mild hepatic insufficiency (see PRECAUTIONS, Hepatic Insufficiency).

Patients with Renal Insufficiency

No dosage adjustment is necessary in patients with renal insufficiency (see CLINICAL PHARMACOLOGY, Special Populations).

Geriatric Patients

No dosage adjustment is necessary in geriatric patients (see CLINICAL PHARMACOLOGY, Special Populations).

Co-administration with Bile Acid Sequestrants

Dosing of ZETIA should occur either 2 hours before or 4 hours after administration of a bile acid sequestrant (see PRECAUTIONS, Drug Interactions).

HOW SUPPLIED

No. 3861 -Tablets ZETIA, 10 mg, are white to off-white, capsule-shaped tablets debossed with "414" on one side. They are supplied as follows:

NDC 66582-414-31 bottles of 30 15
15 Page 16
ZETIA (ezetimibe) 25751817T REV 01
16
NDC 66582-414-54 bottles of 90
NDC 66582-414-74 bottles of 500
NDC 66582-414-28 unit dose packages of 100.

Storage
Store at 25 C (77 F); excursions permitted to 15-30 C (59-86 F). [See USP Controlled Room Temperature.] Protect from moisture.

Issued March 2003 Printed in USA.
Manufactured for: Merck/ Schering-Plough Pharmaceuticals
North Wales, PA 19454, USA By:
Schering Corporation Kenilworth, NJ 07033, USA 16

Page:  << Prev | 1 | 2 | 3